← Back to Search

HN-STAR for Head and Neck Cancer (HN-STAR Trial)

N/A

Recruiting

Research Sponsored by Wake Forest University Health Sciences

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age ≥18 years.

Deemed free of disease at last assessment.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up these variables will be derived from the medical record during the year following the initial visit.

Awards & highlights

HN-STAR Trial Summary

This trial is testing a new way to help people who have been treated for head and neck cancer. It is called HN-STAR. People who have been treated for head and neck cancer can have serious consequences from their cancer and its treatment, ongoing risks of new cancers, and other unrelated illnesses. These concerns pose challenges to the provision of comprehensive care to head and neck cancer survivors. HN-STAR is a way to help cancer care providers understand what each person needs and to provide the best care possible.

Who is the study for?

This trial is for adults over 18 who've been treated for head and neck cancer, are currently free of disease, and have finished chemo or radiation within the last two years. They must be able to complete surveys and attend follow-up clinic visits.Check my eligibility

What is being tested?

HN-STAR, a digital tool designed to improve care for head and neck cancer survivors by tailoring ongoing care based on their reported symptoms. The study compares HN-STAR's effectiveness against usual care in improving patient outcomes over one year.See study design

What are the potential side effects?

Since HN-STAR is a non-medical intervention focusing on monitoring and managing survivorship care plans rather than a drug or medical procedure, it does not have traditional side effects.

HN-STAR Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

My last health check showed no signs of disease.

Select...

I have been diagnosed with a specific type of throat or mouth cancer.

HN-STAR Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline & 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline & 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline & 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in HNC-Specific QOL

Secondary outcome measures

Adherence and surveillance of guideline concordant care

Change in QoL

Change in pain

+4 more

HN-STAR Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: HN-STARExperimental Treatment1 Intervention

Group II: Usual CareActive Control1 Intervention

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterOTHER

1,937 Previous Clinical Trials

587,850 Total Patients Enrolled

Wake Forest University Health SciencesLead Sponsor

1,244 Previous Clinical Trials

1,004,318 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,692 Previous Clinical Trials

40,929,536 Total Patients Enrolled

Media Library

HN-STAR Intervention Clinical Trial Eligibility Overview. Trial Name: NCT04208490 — N/A

Head and Neck Cancers Research Study Groups: Usual Care, HN-STAR

Head and Neck Cancers Clinical Trial 2023: HN-STAR Intervention Highlights & Side Effects. Trial Name: NCT04208490 — N/A

HN-STAR Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04208490 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are eligible to participate in the experiment?

"Indeed, the information found on clinicaltrials.gov reveals that this research project is presently onboarding participants. Initially posted in February 2021, it was most recently updated on September 2nd 2022 and needs 470 volunteers from 25 different healthcare locations."

Answered by AI

How many healthcare facilities are administering this experiment?

"The focus of this trial is based around the Prisma Health Cancer Institute - Butternut in Greenville, South carolina, Carle Cancer Center in Urbana, Colorado, and Rocky Mountain Cancer Centers - Boulder in Boulder Indiana. Additionally there are 25 other sites operating throughout the country."

Answered by AI

Is enrollment for this research endeavor open to new participants?

"Affirmative. As per the information hosted on clinicaltrials.gov, this research is currently recruiting patients; it was first published on February 23rd 2021 and last revised on September 2nd 2022. 470 people are needed to participate at 25 different medical centres in total."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Implementation and Effectiveness Trial of HN-STAR

2021. "Implementation and Effectiveness Trial of HN-STAR". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04208490.